Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.06.17.599374

Cell-surface glycans are quantitative reporters of Golgi dysfunction in single cells

Abstract

Complex sugar polymers known as glycans contribute to the high molecular diversity of the eukaryotic cell surface. The types and levels of glycans on one cell can be sensed by other cells using carbohydrate-specific binding proteins such as lectins, enabling glycans to regulate cell-cell interactions. Glycans are covalently assembled onto proteins and lipids as they traverse the secretory pathway, a tightly regulated process known as glycosylation and carried out by Golgi-resident enzymes. Errors in glycosylation due to the dysfunctional trafficking of enzymes and substrates in the Golgi are implicated in human diseases. Here we ask how much information about Golgi dysfunction is encoded by surface glycans in single cells. This task is challenging due to high cell-to-cell variability in glycan levels. We exploited the loss-of-adhesion driven disorganization of the Golgi in mouse fibroblasts to generate a highly reproducible gradient of Golgi morphology phenotypes, by titrating the Arf1 inhibitor Brefeldin A (BFA). We measured the resulting distribution of cell-surface glycans in single cells using two fluorescently tagged lectin probes (ConA and WGA). A mathematical model of intracellular traffic, parameterized against measurements of Golgi fragmentation and endocytosis, quantitatively explains cell-surface lectin levels across time and BFA concentrations. We used this model to construct an optimal Bayesian decoder and showed that singlecell lectin measurements predict Golgi phenotypes with accuracy far greater than chance. By combining signals from two lectins we further improved prediction accuracy and speed. Such multi-lectin information may be exploited during natural cell-cell communication, and in the development of single-cell diagnostics.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Joshi, P., Satyajith, A., Panda, D., R, R. B., Thattai, M., Balasubramanian, N.. 2024-06-18. Cell-surface glycans are quantitative reporters of Golgi dysfunction in single cells. https://doi.org/10.1101/2024.06.17.599374

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Sequence context and partner availability specify divergent cell fates from a single transcription factor

Transcription factors drive the gene regulatory networks that control developmental transitions, yet which of their many targets a cell uses remains unresolved. Expressing Cebp, Cebp{beta} or Cebp{delta} identically, alone or with Oct4, Sox2, Klf4 and cMyc, gave four outcomes: adipocyte from fibroblasts and neural stem cells, trophectoderm from embryonic stem cells, and myeloid from B cells. Raising Cebp levels changed how many sites it reached, not which sequence it read: clustered motifs maintained somatic enhancers, while spillover onto low-copy sites created de novo enhancers carrying composites of Cebp and cell-type-restricted partners. In fibroblasts, Cebp also redistributed Oct4, Sox2 and Klf4 from early targets, blocking iPSC formation. Supplying the predicted partners rewrote the output: Spi1 redirected Cebp into parallel adipogenic and myeloid programs, via a transient PpargCD45 state using separate enhancers for each; TFAP2C abolished adipogenic conversion. Motif density and partner composites therefore assemble a factor's instructive output in the receiving cell.

cell biology↗

Tracking the conformational dynamics of single molecules in live cells; GTPase cycling in Cdc42 gradients and microclusters

The Rho family of GTPases play a critical role in many cellular processes by acting as molecular switches relying on conformational changes to transition between active and inactive states. The spatial distribution and kinetics of these conformational changes are complex and vary across the cell. We describe here biosensors based on environment-responsive fluorescent dyes, capable of reporting the conformational changes of individual GTPase molecules as they traffic within living cells (SPARC Cdc42 and SPARC Rac1, 'Single Particle Activation Reporter Constructs'). We use SPARC Cdc42 to determine the rates of different steps in GTPase regulation, activation/inactivation and membrane insertion, that together generate localized gradients of Cdc42 activity driving cell motility. The biosensors also revealed heterogeneously distributed clusters of Cdc42, the mechanisms of their activation, and potential roles in polarized motility.

cell biology↗

High-content screening identifies FDA-approved activators of mitophagy

Mitochondrial diseases are highly heterogeneous disorders caused by defects in oxidative phosphorylation, for which only limited therapeutic options are available. The elimination of dysfunctional mitochondria via mitophagy activation is an attractive strategy to treat several mitochondrial diseases, irrespective of the underlying genetic defect. To identify pharmacological activators of this pathway, we performed a high-content screening of 1,971 FDA-approved compounds using cellular reporters of TFEB nuclear translocation and mitophagy. This screening identified 294 compounds that promoted TFEB translocation, nine of which increased the number of mitolysosomes without compromising cell viability or damaging mitochondria. Among the selected compounds, Meptazinol and Ponatinib emerged as the top-ranked mitophagy inducers in fibroblasts from patients with complex I and IV deficiency, respectively, and were prioritised for further characterisation. However, they did not rescue the bioenergetic defect, suggesting that the stimulation of mitophagy per se is not sufficient to ameliorate the OXPHOS defect in mitochondrial diseases. Overall, our findings establish a scalable platform for the identification of pharmacological activators of TFEB and identify candidate compounds for therapeutic modulation of mitophagy.

cell biology↗